AlphaFold3: An Overview of Applications and Performance Insights
- PMID: 40332289
- PMCID: PMC12027460
- DOI: 10.3390/ijms26083671
AlphaFold3: An Overview of Applications and Performance Insights
Abstract
AlphaFold3, the latest release of AlphaFold developed by Google DeepMind and Isomorphic Labs, was designed to predict protein structures with remarkable accuracy. AlphaFold3 enhances our ability to model not only single protein structures but also complex biomolecular interactions, including protein-protein interactions, protein-ligand docking, and protein-nucleic acid complexes. Herein, we provide a detailed examination of AlphaFold3's capabilities, emphasizing its applications across diverse biological fields and its effectiveness in complex biological systems. The strengths of the new AI model are also highlighted, including its ability to predict protein structures in dynamic systems, multi-chain assemblies, and complicated biomolecular complexes that were previously challenging to depict. We explore its role in advancing drug discovery, epitope prediction, and the study of disease-related mutations. Despite its significant improvements, the present review also addresses ongoing obstacles, particularly in modeling disordered regions, alternative protein folds, and multi-state conformations. The limitations and future directions of AlphaFold3 are discussed as well, with an emphasis on its potential integration with experimental techniques to further refine predictions. Lastly, the work underscores the transformative contribution of the new model to computational biology, providing new insights into molecular interactions and revolutionizing the fields of accelerated drug design and genomic research.
Keywords: AlphaFold3; deep learning; prediction accuracy; protein modeling; protein–ligand interactions; structural biology.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Structural Biology of RNA and Protein-RNA Complexes after AlphaFold3.Chembiochem. 2025 Apr 1;26(7):e202401047. doi: 10.1002/cbic.202401047. Epub 2025 Feb 20. Chembiochem. 2025. PMID: 39936575 Review.
-
af3cli: Streamlining AlphaFold3 Input Preparation.J Chem Inf Model. 2025 Apr 28;65(8):3886-3891. doi: 10.1021/acs.jcim.5c00276. Epub 2025 Apr 9. J Chem Inf Model. 2025. PMID: 40202494
-
Advancements in protein structure prediction: A comparative overview of AlphaFold and its derivatives.Comput Biol Med. 2025 Apr;188:109842. doi: 10.1016/j.compbiomed.2025.109842. Epub 2025 Feb 18. Comput Biol Med. 2025. PMID: 39970826 Review.
-
Advancements in Nanobody Epitope Prediction: A Comparative Study of AlphaFold2Multimer vs AlphaFold3.J Chem Inf Model. 2025 Feb 24;65(4):1782-1797. doi: 10.1021/acs.jcim.4c01877. Epub 2025 Feb 10. J Chem Inf Model. 2025. PMID: 39927847
-
Has AlphaFold3 achieved success for RNA?Acta Crystallogr D Struct Biol. 2025 Feb 1;81(Pt 2):49-62. doi: 10.1107/S2059798325000592. Epub 2025 Jan 27. Acta Crystallogr D Struct Biol. 2025. PMID: 39868559 Free PMC article.
Cited by
-
Unveiling the Solvent Effect: DMSO Interaction with Human Nerve Growth Factor and Its Implications for Drug Discovery.Molecules. 2025 Jul 19;30(14):3030. doi: 10.3390/molecules30143030. Molecules. 2025. PMID: 40733301 Free PMC article.
-
Neuropsychopharmacology in the era of artificial intelligence and biomolecule prediction software.NPP Digit Psychiatry Neurosci. 2025;3(1):16. doi: 10.1038/s44277-025-00038-9. Epub 2025 Jun 30. NPP Digit Psychiatry Neurosci. 2025. PMID: 40606791 Free PMC article. Review.
-
In Silico Analysis of Phosphomannomutase-2 Dimer Interface Stability and Heterodimerization with Phosphomannomutase-1.Molecules. 2025 Jun 15;30(12):2599. doi: 10.3390/molecules30122599. Molecules. 2025. PMID: 40572562 Free PMC article.
-
Molecular Insight into the Recognition of DNA by the DndCDE Complex in DNA Phosphorothioation.Int J Mol Sci. 2025 Jun 16;26(12):5765. doi: 10.3390/ijms26125765. Int J Mol Sci. 2025. PMID: 40565227 Free PMC article.
-
Network Pharmacology-Driven Sustainability: AI and Multi-Omics Synergy for Drug Discovery in Traditional Chinese Medicine.Pharmaceuticals (Basel). 2025 Jul 21;18(7):1074. doi: 10.3390/ph18071074. Pharmaceuticals (Basel). 2025. PMID: 40732361 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources